Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Weider Nutrition ending sale of Excel ephedra products -- IPO filing.

This article was originally published in The Tan Sheet

Executive Summary

WEIDER NUTRITION EXCEL HERBALS BRAND DISCONTINUING EPHEDRA product manufacturing and marketing as of Dec. 1, the company states in a Sept. 27 prospectus for a proposed initial public offering. On Sept. 1, Weider decided to discontinue sales of Excel brand products containing the ephedrine source Ma huang and put on the market Excel Ma huang-free alternatives, the prospectus notes. Products containing ephedra accounted for about 3.3%, or approximately $6.2 mil., of sales in the fiscal year ended May 31, the company stated.
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086230

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel